Systematic review: colitis associated with anti-CTLA-4 therapy-Reference-Cited by-同舟云学术

Systematic review: colitis associated with anti-CTLA-4 therapy

Published:2015-06-15 Issue:4 Volume:42 Page:406-417
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Gupta A.¹,De Felice K. M.²,Loftus E. V.²,Khanna S.²

Affiliation:

1. Department of Internal Medicine; University of Texas, Southwestern Medical Center; Dallas TX USA

2. Division of Gastroenterology and Hepatology; Mayo Clinic; Rochester MN USA

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.13281/fullpdf

Reference70 articles.

1. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N Engl J Med,2010

2. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma;Robert;N Engl J Med,2011

3. Highlights of prescribing information [YERVOY ™ (ipilimumab)] [Internet] [updated 2011 Mar] http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/125377s0000lbl.pdf

4. A combination trial of vaccine plus ipilimumab in metastatic castration-resistant prostate cancer patients: immune correlates;Jochems;Cancer Immunol Immunother,2014

5. Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial;Kwon;Lancet Oncol,2014

Cited by 236 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of immunotherapy PD-1 blockade on acute bone cancer pain: Insights from transcriptomic and microbiomic profiling;International Immunopharmacology;2024-12

2. Pembrolizumab related perforated appendicitis;Journal of Oncology Pharmacy Practice;2024-08-02

3. Approach to Patients with Cancer Going to Surgery;Medical Clinics of North America;2024-08

4. Bifidobacterium modulation of tumor immunotherapy and its mechanism;Cancer Immunology, Immunotherapy;2024-04-02

5. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU;Gastroenterología y Hepatología;2024-04